This chapter explores the conflicting views on pharmaceutical companies and weight loss treatments. It discusses the trials for drugs like OZMPEC and WeGovi, the shortage of weight loss drugs, the acquisition of startups by weight loss companies, and the income barriers faced by individuals who can't afford medication.